These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 31535400)
1. MCM7 silencing promotes cutaneous melanoma cell autophagy and apoptosis by inactivating the AKT1/mTOR signaling pathway. Yang Y; Ma S; Ye Z; Zhou X J Cell Biochem; 2020 Feb; 121(2):1283-1294. PubMed ID: 31535400 [TBL] [Abstract][Full Text] [Related]
2. MCM7 amplification and overexpression promote cell proliferation, colony formation and migration in esophageal squamous cell carcinoma by activating the AKT1/mTOR signaling pathway. Qiu YT; Wang WJ; Zhang B; Mei LL; Shi ZZ Oncol Rep; 2017 Jun; 37(6):3590-3596. PubMed ID: 28498460 [TBL] [Abstract][Full Text] [Related]
3. NCAM regulates the proliferation, apoptosis, autophagy, EMT, and migration of human melanoma cells via the Src/Akt/mTOR/cofilin signaling pathway. Li J; Yang R; Yang H; Chen S; Wang L; Li M; Yang S; Feng Z; Bi J J Cell Biochem; 2020 Feb; 121(2):1192-1204. PubMed ID: 31468584 [TBL] [Abstract][Full Text] [Related]
4. Polyphyllin I Promoted Melanoma Cells Autophagy and Apoptosis via PI3K/Akt/mTOR Signaling Pathway. Long J; Pi X Biomed Res Int; 2020; 2020():5149417. PubMed ID: 32733943 [TBL] [Abstract][Full Text] [Related]
5. MCM7 affects the cisplatin resistance of liver cancer cells and the development of liver cancer by regulating the PI3K/Akt signaling pathway. Su D Immunopharmacol Immunotoxicol; 2022 Feb; 44(1):17-27. PubMed ID: 34821526 [TBL] [Abstract][Full Text] [Related]
6. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway. Yin F; Huang X; Xuan Y Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817 [TBL] [Abstract][Full Text] [Related]
7. microRNA-206 is required for osteoarthritis development through its effect on apoptosis and autophagy of articular chondrocytes via modulating the phosphoinositide 3-kinase/protein kinase B-mTOR pathway by targeting insulin-like growth factor-1. Yu Q; Zhao B; He Q; Zhang Y; Peng XB J Cell Biochem; 2019 Apr; 120(4):5287-5303. PubMed ID: 30335903 [TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway. Liu F; Gao S; Yang Y; Zhao X; Fan Y; Ma W; Yang D; Yang A; Yu Y Oncol Rep; 2018 Mar; 39(3):1523-1531. PubMed ID: 29328421 [TBL] [Abstract][Full Text] [Related]
9. Silencing of microRNA-27a facilitates autophagy and apoptosis of melanoma cells through the activation of the SYK-dependent mTOR signaling pathway. Tang H; Xu X; Xiao W; Liao Y; Xiao X; Li L; Li K; Jia X; Feng H J Cell Biochem; 2019 Aug; 120(8):13262-13274. PubMed ID: 30994959 [TBL] [Abstract][Full Text] [Related]
10. CXCL14 inhibits the growth and promotes apoptosis of hepatocellular carcinoma cells via suppressing Akt/mTOR pathway. Bi J; Liu Q; Sun Y; Hu X; He X; Xu C J Recept Signal Transduct Res; 2021 Dec; 41(6):593-603. PubMed ID: 33108937 [TBL] [Abstract][Full Text] [Related]
11. Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT/mTOR signaling pathway in human melanoma cells. Zhao G; Han X; Zheng S; Li Z; Sha Y; Ni J; Sun Z; Qiao S; Song Z Oncol Rep; 2016 Feb; 35(2):1065-74. PubMed ID: 26573768 [TBL] [Abstract][Full Text] [Related]
12. The Flavonol Isoquercitrin Promotes Mitochondrial-Dependent Apoptosis in SK-Mel-2 Melanoma Cell via the PI3K/AKT/mTOR Pathway. Won YS; Kim JH; Lizardo RCM; Min HJ; Cho HD; Hong SM; Seo KI Nutrients; 2020 Nov; 12(12):. PubMed ID: 33260329 [TBL] [Abstract][Full Text] [Related]
13. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling. Xu X; Jiang J; Yao L; Ji B Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267 [TBL] [Abstract][Full Text] [Related]
14. α-Mangostin inhibits DMBA/TPA-induced skin cancer through inhibiting inflammation and promoting autophagy and apoptosis by regulating PI3K/Akt/mTOR signaling pathway in mice. Wang F; Ma H; Liu Z; Huang W; Xu X; Zhang X Biomed Pharmacother; 2017 Aug; 92():672-680. PubMed ID: 28582759 [TBL] [Abstract][Full Text] [Related]
15. Diallyl Disulfide Induces Apoptosis and Autophagy in Human Osteosarcoma MG-63 Cells through the PI3K/Akt/mTOR Pathway. Yue Z; Guan X; Chao R; Huang C; Li D; Yang P; Liu S; Hasegawa T; Guo J; Li M Molecules; 2019 Jul; 24(14):. PubMed ID: 31340526 [TBL] [Abstract][Full Text] [Related]
16. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway. Gu Y; Fei Z; Zhu R Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198 [TBL] [Abstract][Full Text] [Related]
17. RNAi-mediated human Nestin silence inhibits proliferation and migration of malignant melanoma cells by G Yang XH; Xia T; Zhang J; Yang SF; Tang HX; Tang T; Huang ZC; Zhong YS; He F; Xiang AP J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):895-903. PubMed ID: 29270750 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of miR-138 in patients with malignant melanoma through targeting of PDK1 in the PI3K/AKT autophagy signaling pathway. Meng F; Zhang Y; Li X; Wang J; Wang Z Oncol Rep; 2017 Sep; 38(3):1655-1662. PubMed ID: 28731179 [TBL] [Abstract][Full Text] [Related]
19. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells. Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210 [TBL] [Abstract][Full Text] [Related]
20. The farnesyl transferase inhibitor lonafarnib inhibits mTOR signaling and enforces sorafenib-induced apoptosis in melanoma cells. Niessner H; Beck D; Sinnberg T; Lasithiotakis K; Maczey E; Gogel J; Venturelli S; Berger A; Mauthe M; Toulany M; Flaherty K; Schaller M; Schadendorf D; Proikas-Cezanne T; Schittek B; Garbe C; Kulms D; Meier F J Invest Dermatol; 2011 Feb; 131(2):468-79. PubMed ID: 20944654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]